Alon Herschhorn Selected Research

PF 68742

11/2019

Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alon Herschhorn Research Topics

Disease

9	Infections 01/2022 - 05/2003
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 02/2007
1	Vesicular Stomatitis 12/2020
1	Superinfection 01/2020
1	HIV Infections (HIV Infection) 01/2017

Drug/Important Bio-Agent (IBA)

4	Glycoproteins (Glycoprotein)IBA 01/2022 - 08/2015
3	VaccinesIBA 01/2022 - 08/2015
3	AntibodiesIBA 02/2017 - 05/2003
2	Neutralizing AntibodiesIBA 01/2022 - 05/2014
1	PolymersIBA 01/2022
1	AntigensIBA 01/2022
1	CollagenIBA 01/2022
1	CytokinesIBA 01/2022
1	Viral Envelope ProteinsIBA 12/2020
1	CD4 Antigens (CD4 Antigen)IBA 01/2020
1	Capsid Proteins (Capsid Protein)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	PF 68742IBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	EpitopesIBA 02/2017
1	HLA-C Antigens (HLA-C)IBA 12/2010
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 09/2008
1	Pharmaceutical PreparationsIBA 09/2008
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2008
1	NucleosidesIBA 01/2008
1	Peptides (Polypeptides)IBA 02/2007

Therapy/Procedure

1	Therapeutics 01/2020
1	Drug Therapy (Chemotherapy) 08/2010